Hansberger Growth Investors’s Novartis NVS Stock Holding History

Hansberger Growth Investors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$3.97M	Sell	45,645 -695	-1%	-$60.2K	4.5%	9
2020 Q2	$4.05M	Sell	46,340 -323	-0.7%	-$27.9K	4.86%	7
2020 Q1	$3.85M	Buy	46,663 +21,845	+88%	+$1.95M	5.19%	7
2019 Q4	$2.35M	Buy	24,818 +708	+3%	+$63.5K	2.65%	18
2019 Q3	$2.1M	Buy	24,110 +4,004	+20%	+$360K	2.8%	17
2019 Q2	$1.84M	Buy	+20,106	New	+$1.7M	2.47%	18

Other funds holding NVS

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Hansberger Growth Investors's NVS Position: Q3 2020 in Review

Hansberger Growth Investors reduced its Novartis (NVS) stake by 1.5% in Q3 2020, selling an estimated $60.2K and leaving 45,645 shares worth $3.97M. The position accounts for 4.5% of the portfolio, ranked #9.

Hansberger Growth Investors first reported a position in NVS in Q2 2019 and has held it in 6 quarters since. The position peaked at $4.05M in Q2 2020. 1,119 funds tracked by Wall St. Rank hold NVS as of Q3 2020.

Hansberger Growth Investors held 45,645 shares of Novartis worth $3.97M as of Q3 2020.
Hansberger Growth Investors sold 695 Novartis shares in Q3 2020, an estimated $60.2K.
Novartis made up 4.5% of Hansberger Growth Investors's portfolio in Q3 2020, its #9 holding.
Hansberger Growth Investors first reported a position in Novartis in Q2 2019 and has held it in 6 quarters since.
Hansberger Growth Investors's Novartis position peaked at $4.05M in Q2 2020.
1,119 funds tracked by Wall St. Rank held Novartis as of Q3 2020.

Based on Hansberger Growth Investors's 13F filing for Q3 2020, filed 12 Nov 2020.